<p>Clover Health Investments（納斯達克：CLOV - 獲取免費報告）可能會在 2026 年 5 月 6 日星期三市場收盤後公佈其 2026 年第一季度的業績。分析師預計該公司將公佈每股收益為 0.07 美元，季度收入為 7.14894 億美元。投資者可以訪問該公司即將發佈的 2026 年第一季度財報頁面，以獲取關於定於 2026 年 5 月 6 日下午 5:00（東部時間）的電話會議的最新信息。</p>
<ul>
<li>MarketBeat 週迴顧 – 03/03 - 03/07</li>
</ul>
<p>Clover Health Investments（納斯達克：CLOV - 獲取免費報告）上一次發佈財報是在 2 月 26 日星期四。該公司報告季度每股收益為（0.10）美元，低於分析師一致預期的（0.05）美元，差距為（0.05）美元。該公司季度收入為 4.8771 億美元，而分析師預期為 4.6706 億美元。Clover Health Investments 的股本回報率為負 25.17%，淨利潤率為負 4.45%。分析師平均預計 Clover Health Investments 在當前財年和下一個財年將發佈每股收益為 0 美元。</p>
<h2>Clover Health Investments 股價上漲 4.8%</h2>
<p>Clover Health Investments 的股票在星期三開盤價為 2.64 美元。該公司的 50 日移動平均線為 2.02 美元，200 日移動平均線為 2.40 美元。該公司的市值為 13.9 億美元，市盈率為-15.53，貝塔值為 2.24。Clover Health Investments 的 1 年最低價為 1.58 美元，1 年最高價為 3.92 美元。</p>
<h2>華爾街分析師觀點</h2>
<ul>
<li>錯過了 Hims &amp; Hers 的上漲？Clover Health 可能是下一個</li>
</ul>
<p>一些分析師最近對 CLOV 股票發表了看法。Leerink Partners 在 3 月 5 日星期四的報告中將 Clover Health Investments 的目標價從 3.00 美元下調至 2.50 美元，並對該公司給予了 “市場表現” 評級。Weiss Ratings 在 3 月 27 日星期五的報告中重申了對 Clover Health Investments 的 “賣出（d-）” 評級。Wall Street Zen 在 2 月 15 日星期日的報告中將 Clover Health Investments 的評級從 “賣出” 上調至 “持有”。最後，Canaccord Genuity Group 在 3 月 20 日星期五的報告中將 Clover Health Investments 的目標價從 3.70 美元下調至 3.20 美元，並對該公司給予了 “買入” 評級。一位研究分析師對該股票給予了買入評級，三位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “持有”，平均目標價為 2.90 美元。</p>
<p><strong>查看我們關於 Clover Health Investments 的最新股票報告</strong></p>
<h2>Clover Health Investments 的內部買賣情況</h2>
<p>在其他 Clover Health Investments 的新聞中，首席執行官 Brady Patrick Priest 在 3 月 4 日星期三出售了 175,000 股該公司的股票。股票以平均價格 2.17 美元出售，總交易額為 379,750.00 美元。交易完成後，首席執行官持有該公司 1,998,584 股股票，價值約為 4,336,927.28 美元。這筆交易代表了他們持股比例的 8.05% 的減少。該出售在向證券交易委員會提交的文件中披露，文件可通過此鏈接訪問。公司內部人士持有該公司 24.07% 的股份。</p>
<h2>對 Clover Health Investments 的對沖基金觀點</h2>
<p>機構投資者和對沖基金最近對該公司的持倉進行了調整。Sei Investments Co.在第二季度購買了 Clover Health Investments 的新頭寸，價值約為 118,000 美元。Russell Investments Group Ltd.在第三季度購買了 Clover Health Investments 的新頭寸，價值約為 104,000 美元。Virtu Financial LLC 在第三季度購買了 Clover Health Investments 的新頭寸，價值約為 101,000 美元。加拿大養老金計劃投資委員會在第二季度購買了 Clover Health Investments 的新頭寸，價值約為 88,000 美元。最後，Mackenzie Financial Corp 在第三季度購買了 Clover Health Investments 的新頭寸，價值約為 80,000 美元。機構投資者持有該公司 19.77% 的股份。</p>
<h2>關於 Clover Health Investments</h2>
<p>（獲取免費報告）</p>
<p>Clover Health Investments 是一家以技術驅動的醫療保健公司，專注於為老年人羣體提供醫療保險優勢計劃。該公司將保險覆蓋與專有軟件平台相結合，以改善護理協調、結果跟蹤和成本管理。通過利用數據分析，Clover Health 旨在為其成員提供個性化的護理路徑和預防干預措施。</p>
<p>Clover 的核心產品是其 Clover Assistant 平台，該平台從多個來源聚合臨牀和索賠數據，為醫生和護理團隊提供實時洞察。</p>
<h2>進一步閲讀</h2>
<ul>
<li>五隻我們更看好的股票，而不是 Clover Health Investments</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Clover Health Investments 嗎？</h2>
<p>在你考慮 Clover Health Investments 之前，你需要聽聽這個。</p>
<p>MarketBeat 跟蹤華爾街頂級評級和表現最佳的研究分析師及其每天推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 Clover Health Investments 並不在名單上。</p>
<p>雖然 Clover Health Investments 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

三葉草健康

<p>Clover Health Investments (NASDAQ:CLOV) 將於 5 月 6 日公佈 2026 年第一季度財報，預計每股收益為 0.07 美元，收入為 7.1489 億美元。該公司此前報告了 2025 年第四季度每股虧損 0.10 美元。分析師對該股票的評級不一，普遍評級為 “持有”，平均目標價為 2.90 美元。首席執行官 Brady Priest 最近出售了 175,000 股，減少了 8.05% 的持股比例。機構投資者持有該公司 19.77% 的股份，該公司專注於老年人的醫療保險優勢計劃</p>

<p>Clover Health Investments (NASDAQ:CLOV - Get Free Report) will likely be announcing its Q1 2026 results after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of $0.07 per share and revenue of $714.8940 million for the quarter. Investors may visit the the company's upcoming Q1 2026 earning results page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 5:00 PM ET.</p>
<div class="lb-trans"><p>Clover Health Investments（納斯達克：CLOV - 獲取免費報告）可能會在 2026 年 5 月 6 日星期三市場收盤後公佈其 2026 年第一季度的業績。分析師預計該公司將公佈每股收益為 0.07 美元，季度收入為 7.14894 億美元。投資者可以訪問該公司即將發佈的 2026 年第一季度財報頁面，以獲取關於定於 2026 年 5 月 6 日下午 5:00（東部時間）的電話會議的最新信息。</p>
</div><ul>
<li>MarketBeat Week in Review – 03/03 - 03/07</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 03/03 - 03/07</li>
</ul>
</div><p>Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its earnings results on Thursday, February 26th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by ($0.05). The firm had revenue of $487.71 million for the quarter, compared to analysts' expectations of $467.06 million. Clover Health Investments had a negative return on equity of 25.17% and a negative net margin of 4.45%. On average, analysts expect Clover Health Investments to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.</p>
<div class="lb-trans"><p>Clover Health Investments（納斯達克：CLOV - 獲取免費報告）上一次發佈財報是在 2 月 26 日星期四。該公司報告季度每股收益為（0.10）美元，低於分析師一致預期的（0.05）美元，差距為（0.05）美元。該公司季度收入為 4.8771 億美元，而分析師預期為 4.6706 億美元。Clover Health Investments 的股本回報率為負 25.17%，淨利潤率為負 4.45%。分析師平均預計 Clover Health Investments 在當前財年和下一個財年將發佈每股收益為 0 美元。</p>
</div><h2>Clover Health Investments Trading Up 4.8%</h2>
<div class="lb-trans"><h2>Clover Health Investments 股價上漲 4.8%</h2>
</div><p>Clover Health Investments stock opened at $2.64 on Wednesday. The firm has a 50-day moving average of $2.02 and a 200-day moving average of $2.40. The firm has a market cap of $1.39 billion, a P/E ratio of -15.53 and a beta of 2.24. Clover Health Investments has a 1-year low of $1.58 and a 1-year high of $3.92.</p>
<div class="lb-trans"><p>Clover Health Investments 的股票在星期三開盤價為 2.64 美元。該公司的 50 日移動平均線為 2.02 美元，200 日移動平均線為 2.40 美元。該公司的市值為 13.9 億美元，市盈率為-15.53，貝塔值為 2.24。Clover Health Investments 的 1 年最低價為 1.58 美元，1 年最高價為 3.92 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><ul>
<li>Missed the Hims &amp; Hers Rally? Clover Health Could Be Next</li>
</ul>
<div class="lb-trans"><ul>
<li>錯過了 Hims &amp; Hers 的上漲？Clover Health 可能是下一個</li>
</ul>
</div><p>A number of analysts have recently weighed in on CLOV shares. Leerink Partners dropped their target price on shares of Clover Health Investments from $3.00 to $2.50 and set a &#34;market perform&#34; rating for the company in a report on Thursday, March 5th. Weiss Ratings reiterated a &#34;sell (d-)&#34; rating on shares of Clover Health Investments in a report on Friday, March 27th. Wall Street Zen upgraded shares of Clover Health Investments from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Sunday, February 15th. Finally, Canaccord Genuity Group dropped their target price on shares of Clover Health Investments from $3.70 to $3.20 and set a &#34;buy&#34; rating for the company in a report on Friday, March 20th. One research analyst has rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of &#34;Hold&#34; and an average target price of $2.90.</p>
<div class="lb-trans"><p>一些分析師最近對 CLOV 股票發表了看法。Leerink Partners 在 3 月 5 日星期四的報告中將 Clover Health Investments 的目標價從 3.00 美元下調至 2.50 美元，並對該公司給予了 “市場表現” 評級。Weiss Ratings 在 3 月 27 日星期五的報告中重申了對 Clover Health Investments 的 “賣出（d-）” 評級。Wall Street Zen 在 2 月 15 日星期日的報告中將 Clover Health Investments 的評級從 “賣出” 上調至 “持有”。最後，Canaccord Genuity Group 在 3 月 20 日星期五的報告中將 Clover Health Investments 的目標價從 3.70 美元下調至 3.20 美元，並對該公司給予了 “買入” 評級。一位研究分析師對該股票給予了買入評級，三位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “持有”，平均目標價為 2.90 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on Clover Health Investments</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Clover Health Investments 的最新股票報告</strong></p>
</div><h2>Insider Buying and Selling at Clover Health Investments</h2>
<div class="lb-trans"><h2>Clover Health Investments 的內部買賣情況</h2>
</div><p>In other Clover Health Investments news, CEO Brady Patrick Priest sold 175,000 shares of the firm's stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $2.17, for a total transaction of $379,750.00. Following the completion of the transaction, the chief executive officer owned 1,998,584 shares of the company's stock, valued at approximately $4,336,927.28. This trade represents a 8.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this link. Corporate insiders own 24.07% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Clover Health Investments 的新聞中，首席執行官 Brady Patrick Priest 在 3 月 4 日星期三出售了 175,000 股該公司的股票。股票以平均價格 2.17 美元出售，總交易額為 379,750.00 美元。交易完成後，首席執行官持有該公司 1,998,584 股股票，價值約為 4,336,927.28 美元。這筆交易代表了他們持股比例的 8.05% 的減少。該出售在向證券交易委員會提交的文件中披露，文件可通過此鏈接訪問。公司內部人士持有該公司 24.07% 的股份。</p>
</div><h2>Hedge Funds Weigh In On Clover Health Investments</h2>
<div class="lb-trans"><h2>對 Clover Health Investments 的對沖基金觀點</h2>
</div><p>Institutional investors and hedge funds have recently made changes to their positions in the business. Sei Investments Co. bought a new position in shares of Clover Health Investments during the second quarter valued at approximately $118,000. Russell Investments Group Ltd. bought a new position in shares of Clover Health Investments during the third quarter valued at approximately $104,000. Virtu Financial LLC bought a new position in shares of Clover Health Investments during the third quarter valued at approximately $101,000. Canada Pension Plan Investment Board bought a new position in shares of Clover Health Investments during the second quarter valued at approximately $88,000. Finally, Mackenzie Financial Corp bought a new position in shares of Clover Health Investments during the third quarter valued at approximately $80,000. Institutional investors own 19.77% of the company's stock.</p>
<div class="lb-trans"><p>機構投資者和對沖基金最近對該公司的持倉進行了調整。Sei Investments Co.在第二季度購買了 Clover Health Investments 的新頭寸，價值約為 118,000 美元。Russell Investments Group Ltd.在第三季度購買了 Clover Health Investments 的新頭寸，價值約為 104,000 美元。Virtu Financial LLC 在第三季度購買了 Clover Health Investments 的新頭寸，價值約為 101,000 美元。加拿大養老金計劃投資委員會在第二季度購買了 Clover Health Investments 的新頭寸，價值約為 88,000 美元。最後，Mackenzie Financial Corp 在第三季度購買了 Clover Health Investments 的新頭寸，價值約為 80,000 美元。機構投資者持有該公司 19.77% 的股份。</p>
</div><h2>About Clover Health Investments</h2>
<div class="lb-trans"><h2>關於 Clover Health Investments</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members.</p>
<div class="lb-trans"><p>Clover Health Investments 是一家以技術驅動的醫療保健公司，專注於為老年人羣體提供醫療保險優勢計劃。該公司將保險覆蓋與專有軟件平台相結合，以改善護理協調、結果跟蹤和成本管理。通過利用數據分析，Clover Health 旨在為其成員提供個性化的護理路徑和預防干預措施。</p>
</div><p>At the core of Clover's offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams.</p>
<div class="lb-trans"><p>Clover 的核心產品是其 Clover Assistant 平台，該平台從多個來源聚合臨牀和索賠數據，為醫生和護理團隊提供實時洞察。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Clover Health Investments</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，而不是 Clover Health Investments</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=CLOV"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Clover Health Investments Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Clover Health Investments 嗎？</h2>
</div><p>Before you consider Clover Health Investments, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Clover Health Investments 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟蹤華爾街頂級評級和表現最佳的研究分析師及其每天推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而 Clover Health Investments 並不在名單上。</p>
</div><p>While Clover Health Investments currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Clover Health Investments 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

三葉草健康投資公司（CLOV）預計將在週三公佈季度財報